The market has been expecting it which is why the share price has nearly tripled over the past twelve months. Sell the news.
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%